Biosensors Market focused on drug discovery and development is projected to grow at an annualized rate of 9% during the period 2023-2035

In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the growing demand for inexpensive and effective techniques for analyzing potential drug candidates
Roots Analysis has announced the addition of “Biosensors Market: Focus on Drug Discovery and Drug Development, 2023 - 2035” report to its list of offerings.
A number of drug developers are already using novel biosensors for various drug discovery applications to address the concerns associated with high rate of failures of drug development programs and requirement of high capital investments. As the adoption of biosensors, specifically for drug discovery, increases amongst innovators in the pharma and biopharma industry, lucrative opportunities are expected to be created for players engaged in the biosensors for drug discovery market.
Key Market Insights
Currently, more than 80 biosensors are being developed by various stakeholders, across the world
Majority of the biosensors (64%) engaged in this domain are optical biosensors, followed by electrochemical biosensors (25%), quartz crystal microbalance biosensors (5%) and thermal biosensors (5%). Close to 95% of the biosensors are used for lead identification step in drug discovery. Further, 15% of the biosensors claim to support all the steps in drug discovery.
Get Detailed Report: https://www.rootsanalysis.com/report...
Over USD 1.2 billion invested in various domain focused initiatives, since 2018
Specifically, in 2021, industry players raised close to USD 600 billion. In addition, majority of the companies (66%) primarily received funding through venture capital rounds. Further, around 60% of the total funding instances were reported by players headquartered in the US.
In recent years, several global events related to biosensors in drug discovery were organized
Majority of the events related to biosensors in drug discovery were organized in Europe (45%). It is worth highlighting that the main agenda of these events was to discuss the development and challenges associated with the biosensors in drug discovery domain.
370+ patents related to biosensors in drug discovery have been granted / filed between 2018-2022
R&D activity related to biosensors in drug discovery is largely concentrated in North America, considering the fact that 70% of the total number of patents were filed in this region. In addition, most of the patents in this domain are granted patents (55%), followed by patent applications (44%).
North America and Europe are anticipated to capture over 70% of the market share, by 2035
In addition, the market in Asia Pacific is likely to grow at a relatively faster pace (10%) in the long term. Further, in 2035, biosensors market for drug discovery applications for academic / research institutes is expected to capture the majority share (~60%) of the total market.
Request for Customization @ https://www.rootsanalysis.com/report...
Key Questions Answered
• Who are the key players engaged in the biosensors in drug discovery market?
• What is the relative competitiveness of different biosensors being developed for drug discovery applications?
• What are the key agenda items being discussed in various global events / conferences related to biosensors in drug discovery?
• What is the focus area of the ongoing research activity related to biosensors in drug discovery?
• How is the intellectual property landscape for biosensors in drug discovery likely to evolve in the foreseen future?
• What are the factors that are likely to influence the evolution of this market?
• How is the current and future market opportunity likely to be distributed across key segments?
The financial opportunity within the biosensors in drug discovery market has been analyzed across the following segments:
Type of Biosensor
• Optical
• Electrochemical
• Thermal
• Others
Type of End User
• Academic / Research Institutes
• Industry Players
Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Latin America
• MENA
• Rest of the World
The report features inputs from eminent industry stakeholders, according to whom, continuous growth of biosensors market for drug discovery applications is primarily driven by the increasing adoption for such products. The report includes detailed transcripts of discussions held with the following experts:
• Bill Rader (Chief Executive Officer, Efferent Labs)
• Anne Marie Quinn (Chief Executive Officer, Montana Molecular)
• Laurent Sabbagh (Associate Director and Head of Biology, Domain Therapeutics).
The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its biosensor product portfolio, recent developments and an informed future outlook.
• Agilent Technologies
• Axion Biosciences
• BioNavigations
• Creoptix
• Cytiva
• Dynamic Biosensors
• Malvern Panalytical
• Microvacuum
• Sartorius
• Tempo Bioscience
Request for Sample: https://www.rootsanalysis.com/report...

Read Our Latest Blogs:
https://www.rootsanalysis.com/blog/w...
https://www.rootsanalysis.com/blog/s...
https://www.rootsanalysis.com/blog/r...
https://www.rootsanalysis.com/blog/s...
https://www.rootsanalysis.com/blog/c...

Visit for More Insights: https://www.rootsanalysis.com/report...
Read Our Latest Press Release: https://www.rootsanalysis.com/press-...
Latest Blogs On Healthcare Industry: https://www.rootsanalysis.com/blog/

In comparison to batch production methods, continuous manufacturing is not only cost and time-efficient, but also enables reduction in energy and manpower requirement, footprint, process-related errors and product inconsistencies
Roots Analysis has announced the addition of “Continuous Manufacturing (Small Molecules and Biologics) Market (2nd Edition), 2022 - 2035” report to its list of offerings
The outbreak COVID-19 pandemic had disruptive impact on the overall pharmaceutical supply chain, due to the absence of workers at manufacturing sites and distribution networks’ restrictions. Continuous manufacturing offers a practicable solution as the continuous processes are automated on a larger scale, and the FDA and other regulatory bodies have demonstrated interest in the transition to modern manufacturing methods, including continuous manufacturing.
Key Market Insights
Over 70 companies claim to have expertise in continuous manufacturing of small molecule / biologic drugs
The continuous manufacturing market landscape is dominated by well-established players (founded before 1990), which represent nearly 60% of the total number of stakeholders. Amongst these, close to 50% players are headquartered in Europe, followed by those based in North America (33%).
Partnership activity in this field has increased at a CAGR of 37%, between 2013 and 2021
Research agreements and technology enhancement (~20%) emerged as the most common type of partnership model adopted by stakeholders engaged in this industry. 55% of the total deals were established post 2017, with the maximum activity being reported in 2018 (13).
Get Detailed Report: https://www.rootsanalysis.com/report...
Over 60 expansion initiatives were undertaken in the period 2013-2021
Majority of the expansion projects (48%) were focused on establishment of a new facility / plant, followed by the initiatives taken for incorporating continuous manufacturing technology (30%) into the existing facilities of different companies. Additionally, close to 50% of the total number of expansions were undertaken in Europe.
Over 65% of the installed continuous manufacturing capacity belongs to large players
More than 95% of the annual continuous manufacturing capacity was dedicated to the production of small molecules. In addition, 60% of the overall capacity is installed in Europe, followed by North America (26%).
Around 120 grants were awarded to support ongoing R&D activities related to continuous manufacturing, between 2016 and 2021
Collectively, the capital amount awarded to support R&D in this field was estimated to be worth USD 58 million. It is worth noting that NIGMS emerged to be the most active organization which funded 30+ projects for a period of 1-10 years. A significant proportion of grants identified in the report were awarded to the Purdue University, followed by those awarded to Massachusetts Institute of Technology.
Several patents have been filed / granted related to continuous manufacturing
More than 95% of the patents were filed / granted; of these, more than 70% have been granted to non-academic players. Further, over 45% of the total number of patents were filed / granted in North America, followed by WIPO (~30%)
North America and Europe are anticipated to capture close to 80% share in the market, by 2035
Owing to increased investment and growing initiatives for adoption of continuous manufacturing in pharmaceutical domain in order to meet the future demand, the commercial market is likely to grow at a relatively faster pace at a CAGR of 17.73% in the long term. Further, among the continuous manufacturers, contract manufacturers are expected to dominate the market in 2035, capturing more than 75% of the market share.
Request for Customization @ https://www.rootsanalysis.com/report...
Key Questions Answered
• Who are the leading players providing in the continuous manufacturing services?
• In which regions are the majority of facilities related to continuous manufacturers located?
• What is the installed, global capacity for continuous manufacturing?
• Which partnership models are commonly adopted by stakeholders engaged in providing continuous manufacturing services?
• Who are the other key stakeholders (modular facility providers and technology / equipment developers) in this domain?
• Which factors are likely to influence the evolution of market?
• How has the patent landscape evolved over the last several years?
• Which research institutes have received majority of grants related to continuous manufacturing?
• Which organizations have taken significant in-house initiatives in the field of continuous manufacturing?
• How is the current and future market opportunity likely to be distributed across key market segments?
The financial opportunity within the continuous manufacturing market has been analysed across the following segments:
Purpose of Manufacturing
• In-House
• Contract service
Scale of Operation
• Commercial
• Preclinical / Clinical
Type of Continuous Manufacturing related Service
• API Manufacturing
• Final Dosage Form Manufacturing
Type of Drug Molecule
• Biologic
• Small Molecule
Key Geographical Regions
• North America
• Europe
• Asia Pacific
The research includes profiles of key players (listed below); each profile features a brief overview of the company, recent developments (including partnerships and collaborations) and an informed future outlook.
• AbbVie Contract Manufacturing
• ACG Group
• Ajinomoto Bio-Pharma Services
• Almac Group
• Aurobindo Pharma
• Boehringer Ingelheim
• Cambrex
• Colorcon
• Corden Pharma
• GEA Group
• Glatt Pharma
• Hovione
• Kaneka
• Lonza
• Patheon
• SK Pharmteco
• STA Pharmaceuticals
• WuXi AppTec
Request for Sample: https://www.rootsanalysis.com/report...

Read Our Latest Blogs:
https://www.rootsanalysis.com/blog/8...
https://www.rootsanalysis.com/blog/3...
https://www.rootsanalysis.com/blog/n...
https://www.rootsanalysis.com/blog/b...
https://www.rootsanalysis.com/blog/c...

Visit for More Insights: https://www.rootsanalysis.com/report...
Read Our Latest Press Release: https://www.rootsanalysis.com/press-...
Latest Blogs On Healthcare Industry: https://www.rootsanalysis.com/blog/

Our Service Portfolio: Pipeline Tracking | Publication Analysis | Investment Analysis | Market Assessment | Competitive Profiling | Commercial Strategy and Business Development

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]